Contact: Science Press Package
American Association for the Advancement of Science
Caption: University of Pennsylvania cancer investigators Carl June, David Porter, Bruce Levine and Michael Kalos discuss their work using genetically modified T cells for the treatment of patients with chronic lymphocytic leukemia. This video relates to a paper that appeared in the Aug. 10, 2011, issue of Science Translational Medicine, published by AAAS. The paper, by Dr. M. Kalos of University of Pennsylvania in Philadelphia, Pa., and colleagues, was titled, "T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia."
Credit: Video courtesy of Penn Medicine
Usage Restrictions: Please cite the owner of the video when publishing. This video may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.